Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.30 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.30 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL633576 | 0.90 | SMN1; SMN2 (0.37) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| SCHEMBL27566530 | 0.80 | — | — | |
| Hydrochloric Acid SCHEMBL1323084 | 0.75 | SMN1; SMN2 (0.48) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| Hydrochloric Acid SCHEMBL10571289 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL655143 | 0.73 | SMN1; SMN2 (0.46) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| Hydrochloric Acid SCHEMBL3331961 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL2652402 | 0.73 | — | — | |
| SCHEMBL10925528 | 0.72 | TSHR (0.43) | CA14CA12CA1CA2HCAR2 | |
| SCHEMBL109870 | 0.72 | ALDH1A1 (0.46) | ALDH1A1KMT2AMEN1HCAR2TSHR | |
| SCHEMBL590894 | 0.71 | SMN1; SMN2 (0.50) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117486855-A | Process for preparing 2, 5-thiophenedicarboxylic acid | 三门峡奥科科技有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-109481430-A | Thiodiglycolic acid dimethyl ester is in the application for preparing antithrombotic and neurodegenerative drugs | 北京北朋科技有限公司 | 2019-03-19 | — | — | CN | claimed |
| CN-108976542-A | Drinking water packaging bottle and preparation method thereof | 苏州华新达饮品技术有限公司 | 2018-12-11 | — | — | CN | claimed |
| CN-108794916-A | A kind of antibiotic plastic | 淄博齐鼎立专利信息咨询有限公司 | 2018-11-13 | — | — | CN | claimed |
| CN-108359189-A | A kind of antibiotic plastic | 淄博齐鼎立专利信息咨询有限公司 | 2018-08-03 | — | — | CN | claimed |
| CN-105949643-A | Antibacterial plastic | 淄博夸克医药技术有限公司 | 2016-09-21 | — | — | CN | claimed |
| CN-102675605-B | Soluble poly-6,9-phenanthrene thiophthene and preparation method and application thereof | UNIV SOUTH CHINA TECH | 2013-10-30 | — | — | CN | claimed |
| CN-102617834-B | Soluble poly-5,10-phenanthrene thiophene and preparing method and application thereof | UNIV SOUTH CHINA TECH | 2013-09-25 | — | — | CN | claimed |
| CN-102802605-A | Stable lipid formulations of apoptosis promoters | ABBOTT LAB | 2012-11-28 | — | — | CN | claimed |
| CN-102558196-A | Method for preparing (3,4)-1,4-dioxoethylidene thiophene-2'-methanol | ZHANGJIAGANG BEILI CHEMICALS CO LTD | 2012-07-11 | — | — | CN | claimed |
| EP-2424499-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | Abbott Laboratories (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | claimed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | claimed |
| US-4122258-A | Process for producing desacetoxycephalosporin derivatives by heating a penicillin-1-oxide in presence of an organic sulfide | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1978-10-24 | — | — | US | claimed |
| CN-117486855-A | Process for preparing 2, 5-thiophenedicarboxylic acid | 三门峡奥科科技有限公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117486855-A | Process for preparing 2, 5-thiophenedicarboxylic acid | 三门峡奥科科技有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20230140494-A1 | ADDITIVE FOR ELECTROLYTE OF SECONDARY LITHIUM BATTERY, ELECTROLYTE FOR SECONDARY LITHIUM BATTERY, AND SECONDARY LITHIUM BATTERY COMPRISING SAME | SAMSUNG SDI CO., LTD. (KR) | 2023-05-04 | — | — | US | disclosed |
| EP-0466200-A1 | Aminocarboxylic acids and derivatives thereof | NYCOMED IMAGING AS (NO) | 1992-01-15 | — | — | EP | disclosed |
| WO-1989000557-A1 | AMINOPOLYCARBOXYLIC ACIDS AND DERIVATIVES THEREOF | COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) | 1989-01-26 | — | — | WO | disclosed |
| US-4122258-A | Process for producing desacetoxycephalosporin derivatives by heating a penicillin-1-oxide in presence of an organic sulfide | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1978-10-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | BCL2, BAX, BCOR | SMN1; SMN2 820/4885CA14 4616/4885ALDH1A1 3985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.